Preliminary experience with intra-arterial nicardipine in patients with acute ischemic stroke

Neurocritical Care

Volumn 7, Issue 1, 2007, Pages 53-57

  Shah, Qaisar A ^a,b   Georgiadis, Alexandros ^a   Suri, M Fareed K ^a   Rodriguez, Gustavo ^a   Qureshi, Adnan I ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MMC 295 ^*  (United States)

Author keywords

Intra arterial thrombolysis; Ischemic stroke; Mechanical thrombolysis; Nicardipine; Recanalization

Indexed keywords

FIBRINOLYTIC AGENT; NICARDIPINE; RETEPLASE;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FLUID RESUSCITATION; HEART RATE; HUMAN; MALE; MEAN ARTERIAL PRESSURE; MONOTHERAPY; NEUROLOGIC EXAMINATION; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECANALIZATION; THROMBECTOMY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY; BRAIN ISCHEMIA; CALCIUM CHANNEL BLOCKERS; COMBINED MODALITY THERAPY; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; NICARDIPINE; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; STROKE; THROMBECTOMY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 36949019358     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12028-007-0035-7     Document Type: Article

References (13)

1. Sabbatini M et al. Neuroprotective effect of treatment with calcium antagonists on hypertensive retina. Clin Exp Hypertens 2002;24(7-8):727-40
2. Amenta F, Tomassoni D. Treatment with nicardipine protects brain in an animal model of hypertension-induced damage. Clin Exp Hypertens 2004;26(4):351-61
3. Kittaka M et al. Attenuation of brain injury and reduction of neuron-specific enolase by nicardipine in systemic circulation following focal ischemia and reperfusion in a rat model. J Neurosurg 1997;87(5):731-7
4. Mikami C et al. Effect of nicardipine and magnesiumon cerebral infarction-brain surface perfusion technique. Cerebrovasc Dis 2001;11(1):44-50
5. Flamm ES. The potential use of nicardipine in cerebrovascular disease. Am Heart J 1989;117(1):236-42
6. Rosenbaum DM et al. Pilot study of nicardipine for acute ischemic stroke. Angiology 1990;41(11 Pt 2):1017-22
7. ++ antagonist and acute brain ischemia: effects of nilvadipine and nicardipine on middle cerebral artery occlusion in rats]. Nippon Geka Hokan 1991;60(1):38-44
8. Badjatia N et al. Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. AJNR Am J Neuroradiol 2004;25(5):819-26
9. Qureshi AI. New grading system for angiographic evaluation of arterial occlusions and recanalization response to intra-arterial thrombolysis in acute ischemic stroke. Neurosurgery 2002;50(6):1405-14; discussion 1414-5
10. Arnold M et al. Recanalisation of middle cerebral artery occlusion after intra-arterial thrombolysis: different recanalisation grading systems and clinical functional outcome. J Neurol Neurosurg Psychiatry 2005;76(10):1373-6
11. Flamm ES et al. Dose-escalation study of intravenous nicardipine in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 1988;68(3):393-400
12. Haley EC Jr, Kassell NF, Torner JC. A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 1993;78(4):537-47
13. Haley EC Jr et al. A randomized trial of two doses of nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg, 1994;80(5):788-96